Published in Eur Respir J on September 01, 2000
Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax (2012) 3.08
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
An automated communication system in a contact registry for persons with rare diseases: scalable tools for identifying and recruiting clinical research participants. Contemp Clin Trials (2008) 1.52
Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children. Arch Dis Child (2004) 1.39
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros (2014) 1.17
Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome (2014) 1.05
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLoS One (2014) 1.02
Chronic pancreatitis and cystic fibrosis. Gut (2003) 0.98
"CF asthma": what is it and what do we do about it? Thorax (2002) 0.97
Pneumothorax in cystic fibrosis. J Thorac Dis (2014) 0.91
Asthma in cystic fibrosis. J R Soc Med (2003) 0.88
High-resolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2008) 0.88
Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J (2001) 0.78
Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int J Pediatr (2010) 0.78
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ann Thorac Med (2017) 0.75
Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody. J R Soc Med (2009) 0.75
An estimate of the burden of serious fungal diseases in Greece. Eur J Clin Microbiol Infect Dis (2016) 0.75
TESTS TO ASSESS SENSITIZATION TO ASPERGILLUS FUMIGATUS IN CYSTIC FIBROSIS. Rev Paul Pediatr (2017) 0.75
Computational modelling of visual attention. Nat Rev Neurosci (2001) 9.06
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet (2001) 6.88
Invariant visual representation by single neurons in the human brain. Nature (2005) 6.41
The highly irregular firing of cortical cells is inconsistent with temporal integration of random EPSPs. J Neurosci (1993) 5.77
Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science (2000) 5.57
A saliency-based search mechanism for overt and covert shifts of visual attention. Vision Res (2000) 5.11
A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci (2000) 4.85
Shifts in selective visual attention: towards the underlying neural circuitry. Hum Neurobiol (1985) 4.78
Are we aware of neural activity in primary visual cortex? Nature (1995) 4.74
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet (1992) 4.23
Cellular factors couple recombination with growth phase: characterization of a new component in the lambda site-specific recombination pathway. Cell (1987) 3.94
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature (1988) 3.57
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet (2001) 3.50
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Recurrent excitation in neocortical circuits. Science (1995) 3.38
Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet (1991) 3.37
Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest (1998) 3.32
Identification of the cystic fibrosis gene. BMJ (1990) 3.28
Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet (1990) 3.27
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (1991) 3.26
Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol (1997) 3.23
Category-specific visual responses of single neurons in the human medial temporal lobe. Nat Neurosci (2000) 3.21
Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int J Syst Bacteriol (1995) 3.16
The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child (1979) 3.16
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J (2000) 3.14
Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J (1972) 3.06
G inversion in bacteriophage Mu DNA is stimulated by a site within the invertase gene and a host factor. Cell (1985) 3.00
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Computational vision and regularization theory. Nature (1985) 2.87
The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem (1994) 2.84
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol (1996) 2.83
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr (2001) 2.78
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Purification and properties of the Escherichia coli host factor required for inversion of the G segment in bacteriophage Mu. J Biol Chem (1986) 2.75
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet (2001) 2.64
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol (1996) 2.55
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Cystic fibrosis in adolescents and adults. Thorax (1987) 2.47
Synaptic background activity influences spatiotemporal integration in single pyramidal cells. Proc Natl Acad Sci U S A (1991) 2.46
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother (1986) 2.43
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38
Nonlinear interactions in a dendritic tree: localization, timing, and role in information processing. Proc Natl Acad Sci U S A (1983) 2.38
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Comparison of discharge variability in vitro and in vivo in cat visual cortex neurons. J Neurophysiol (1996) 2.27
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Constraints on cortical and thalamic projections: the no-strong-loops hypothesis. Nature (1998) 2.17
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J (1979) 2.15
The elusive T cell receptor. Transplant Rev (1972) 2.14
X-ray structure of sensory rhodopsin II at 2.1-A resolution. Proc Natl Acad Sci U S A (2001) 2.12
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
From stimulus encoding to feature extraction in weakly electric fish. Nature (1996) 2.09
Retinal ganglion cells: a functional interpretation of dendritic morphology. Philos Trans R Soc Lond B Biol Sci (1982) 2.08
Attention activates winner-take-all competition among visual filters. Nat Neurosci (1999) 2.04
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Three-dimensional structure of the E. coli DNA-binding protein FIS. Nature (1991) 2.01
Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. J Antimicrob Chemother (1987) 2.00
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Consciousness and neuroscience. Cereb Cortex (1998) 1.99
Effect of lipid composition on the calcium/adenosine 5'-triphosphate coupling ratio of the Ca2+-ATPase of sarcoplasmic reticulum. Biochemistry (1984) 1.98
Evaluation of an immunological score to assess the risk of severe infection in heart recipients. Transpl Infect Dis (2014) 1.98
DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia. J Clin Microbiol (1991) 1.97
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax (1992) 1.97
Imagery neurons in the human brain. Nature (2000) 1.95
Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol (2000) 1.95
Candidate genes for the hypoxic tumor phenotype. Cancer Res (2000) 1.94
The E.coli fis promoter is subject to stringent control and autoregulation. EMBO J (1992) 1.92
Temporal precision of spike trains in extrastriate cortex of the behaving macaque monkey. Neural Comput (1996) 1.87
Encoding of visual information by LGN bursts. J Neurophysiol (1999) 1.85
Shunting inhibition does not have a divisive effect on firing rates. Neural Comput (1997) 1.84
Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods (1981) 1.83
Microbial load of drinking water reservoir tributaries during extreme rainfall and runoff. Appl Environ Microbiol (2002) 1.81
Electrical interactions via the extracellular potential near cell bodies. J Comput Neurosci (1999) 1.81
Analgesia for labor pain: a cost model. Anesthesiology (2000) 1.80
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Sparse but not 'grandmother-cell' coding in the medial temporal lobe. Trends Cogn Sci (2008) 1.76
Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med (1989) 1.75
Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol (1998) 1.74
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (2011) 1.74
The control of retinogeniculate transmission in the mammalian lateral geniculate nucleus. Exp Brain Res (1986) 1.73
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule. J Biol Chem (1997) 1.68
How voltage-dependent conductances can adapt to maximize the information encoded by neuronal firing rate. Nat Neurosci (1999) 1.68
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax (1990) 1.67
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom. BMJ (1993) 1.65
Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax (1990) 1.65
Quality of life in adults with cystic fibrosis. Thorax (1996) 1.64
Ultrasonographic assessment of inflammatory bowel disease in children: comparison with ileocolonoscopy. J Pediatr (1997) 1.63
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Computational neuroscience. Science (1988) 1.61
Increased bronchial chloride concentration in cystic fibrosis. Scand J Clin Lab Invest (1989) 1.60
Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol (1993) 1.60